In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eighteen research firms that are currently covering the company ...

Early moves by the president raise questions about what direction his second-term policy on drug costs will take.